Literature DB >> 15882933

Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer.

Desmond Yip1, David Goldstein.   

Abstract

Entities:  

Year:  2005        PMID： 15882933     DOI： 10.1016/j.ctrv.2005.03.003

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  1 in total

1.  Complete pathological response following down-staging chemoradiation in locally advanced pancreatic cancer: challenging the boundaries.

Authors:  A Z Khan; V Pitsinis; S S Mudan
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.